Caveolin-1 interferes cell growth of lung cancer NCI-H446 cell through the interactions with phospho-ERK1/2, estrogen receptor and progestin receptor

Biomedicine and Pharmacotherapy

Volumn 66, Issue 4, 2012, Pages 242-248

  Sun, Ming Zhong ^a   Guan, Zhuzhu ^a   Liu, Shuqing ^a   Zhou, Xin ^a   Wang, Na ^a   Shao, Shujuan ^a   Lin, Dongmei ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Caveolin 1; Cell cycle; Cell growth; Small cell lung cancer cell

Indexed keywords

CAVEOLIN 1; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER CELL NCI H446; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE S PHASE; CELL INTERACTION; CELL LINE; CELL PROLIFERATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; TUMOR SUPPRESSOR GENE;

CAVEOLIN 1; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SMALL CELL LUNG CARCINOMA; TRANSFECTION;

EID: 84862490454     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.11.003     Document Type: Article

References (29)

1. Mercier I., Casimiro M.C., Zhou J., Wang C., Plymire C., Bryant K.G., et al. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. Am J Pathol 2009, 174(4):1172-1190.
2. Quest A.F., Gutierrez-Pajares J.L., Torres V.A. Caveolin-1: an ambiguous partner in cell signaling and cancer. J Cell Mol Med 2008, 12(4):1130-1150.
3. Yeh D., Chen C., Sun M.Z., Shao S., Hao L., Song Y., et al. Caveolin-1 is an important factor for the metastasis and proliferation of human small cell lung cancer NCI-H446 cell. Anat Rec (Hoboken) 2009, 292(10):1584-1592.
4. Williams T.M., Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005, 288(3):C494-C506.
5. Sunaga N., Miyajima K., Suzuki M., Sato M., White M.A., Ramirez R.D., et al. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res 2004, 64(12):4277-4285.
6. Wheatley-Price P., Ma C., Ashcroft L.F., Nankivell M., Stephens R.J., White S.C., et al. The strength of female sex as a prognostic factor in small cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester lung group and Medical research council clinical trials unit. Ann Oncol 2010, 21(2):232-237.
7. Miki Y., Abe K., Suzuki S., Suzuki T., Sasano H. Suppression of estrogen actions in human lung cancer. Mol Cell Endocrinol 2011, 340(2):168-174.
8. Engelman J.A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T., et al. Caveolin-mediated regulation of signaling along the p42/44-MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 1998, 428(3):205-211.
9. Fiucci G., Ravid D., Reich R., Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 2002, 21(15):2365-2375.
10. Lu M.L., Schneider M.C., Zheng Y., Zhang X., Richie J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001, 276(16):13442-13451.
11. Kato K., Hida Y., Miyamoto M., Hashida H., Shinohara T., Itoh T., et al. Over-expression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 2002, 94(4):929-933.
12. Rajjayabun P.H., Garg S., Durkan G.C., Charlton R., Robinson M.C., Mellon J.K. Caveolin-1 expression is associated with high-grade bladder cancer. Urology 2001, 58(5):811-814.
13. Park S.S., Kim J.E., Kim Y.A., Kim Y.C., Kim S.W. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 2005, 47(6):625-630.
14. Bender F.C., Reymond M.A., Bron C., Quest A.F. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 2000, 60(20):5870-5878.
15. Wiechen K., Sers C., Agoulnik A., Arlt K., Dietel M., Schlag P.M., et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 2001, 158(3):833-839.
16. Sanna E., Miotti S., Mazzi M., De Santis G., Canevari S., Tomassetti A. Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells. Exp Cell Res 2007, 313(7):1307-1317.
17. Kato T., Miyamoto M., Kato K., Cho Y., Itoh T., Morikawa T., et al. Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. Cancer Lett 2004, 214(1):121-128.
18. Yu J.H., Wei Q., Qi F.J., Xu H.T., Wang E.H. Significance of caveolin-1 expression in primary lung cancer (in Chinese). Zhonghua Bing Li Xue Za Zhi 2006, 35(11):664-668.
19. Galbiati F., Volonte D., Liu J., Capozza F., Frank P.G., Zhu L., et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21 (WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001, 12(8):2229-2244.
20. Martin S., Favot L., Matz R., Lugnier C., Andriantsitohaina R. Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2. Biochem Pharmacol 2003, 65(4):669-675.
21. Hulit J., Bash T., Fu M., Galbiati F., Albanese C., Sage D.R., et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 2000, 275(28):21203-21209.
22. Galbiati F., Volonte D., Engelman J.A., Watanabe G., Burk R., Pestell R.G., et al. Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44-MAP kinase cascade. EMBO J 1998, 17(22):6633-6648.
23. Engelman J.A., Wykoff C.C., Yasuhara S., Song K.S., Okamoto T., Lisanti M.P. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 1997, 272(26):16374-16381.
24. Wikman H., Kettunen E., Seppanen J.K., Karjalainen A., Hollmen J., Anttila S., et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002, 21(37):5804-5813.
25. Razani B., Altschuler Y., Zhu L., Pestell R.G., Mostov K.E., Lisanti M.P. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry 2000, 39(45):13916-13924.
26. Ahmad N., Kumar R. Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett 2011, 300(1):1-9.
27. Bennett N., Hooper J.D., Lee C.S., Gobe G.C. Androgen receptor and caveolin-1 in prostate cancer. IUBMB Life 2009, 61(10):961-970.
28. Li L., Yang G., Ebara S., Satoh T., Nasu Y., Timme T.L., et al. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 2001, 61(11):4386-4392.
29. Wang X., Feng S., Zhang H., Wang Y., Cui Y., Wang Z., et al. RNA inference-mediated caveolin-1 down-regulation decreases estrogen receptor alpha (ERα) signaling in human mammary epithelial cells. Mol Biol Rep 2011, 38(2):761-768.